FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...

As one TikTok user explained on the platform, she noticed that her stools were thinner than normal, along with other red-flag ...

Colorectal cancer is the third-most common type of cancer around the world. In the earlier stages, it can be tough to catch. The symptoms, like diarrhea, abdominal pain and anemia, can easily be ...

Gangdong Kyunghee University Hospital (Director Lee Woo-in) obtained the first grade in all the results of the adequacy ...

America's ultraprocessed diet may be a key culprit behind rising colon cancer rates in younger adults, a new study suggests. The study in the journal Gut found higher levels of inflammation in ...

Catholic Kwandong University International St. Mary's Hospital recently announced that it has obtained the first grade in the ...

Seed oils (sunflower, sesame, etc.) are not driving the surge in colon cancer cases among younger people. (Science Feedback) ...

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy ...

Cancer care is a complex and continually advancing field, including prevention, diagnosis, treatment, and supportive care for ...